Literature DB >> 10097432

HLA class II gene and haplotype diversity in the population of the island of Hvar, Croatia.

Z Grubić1, R Zunec, E Cecuk-Jelicić, V Kerhin-Brkljacić, D Kastelan, L Barać, B Janićijević, I Martinović, M Pericić, L A Bennett, P Rudan, A Kastelan.   

Abstract

The DRB1, DRB3, DRB5, DQA1 and DQB1 allele polymorphisms were analysed in 3 western and 3 eastern villages of the island of Hvar using PCR-SSOP method and 12th International Workshop primers and probes. Three DQB1 alleles (*0304, *0305, *0607) detected in the population of the island of Hvar (HP) have not yet been observed in general Croatian population (GCP). Significant differences were observed between two regions of Hvar for: a) DRB1*0701 allele (p < 0.001), b) DQA1*0201 allele (p < 0.01), and c) DRB1*0101-DQA1*0101-DQB1*0501 haplotypic association (p < 0.05). Two unusual haplotypic associations, which have not yet been described in general Croatian population (GCP), DRB1*0101-DQA1*0102-DQB1*0501 and DRB1*1501-DQA1 *0102-DQB1*0604 were observed in the population from the island of Hvar (HP). Measures of genetic kinship and genetic distances revealed isolation and clusterization which coincides with the known ethnohistorical, as well as biological and biocultural data obtained from a series of previous investigations. The five studied village subpopulations formed two clusters (East-West) to which the far eastern village (with the highest rii of 0.0407) joined later, thus indicating possible impact of historical immigrations from the mainland.

Entities:  

Mesh:

Year:  1998        PMID: 10097432

Source DB:  PubMed          Journal:  Coll Antropol        ISSN: 0350-6134


  1 in total

1.  HLA-A, -B, -C, -DRB1, -DQA1, and -DQB1 allele and haplotype frequencies defined by next generation sequencing in a population of East Croatia blood donors.

Authors:  Stana Tokić; Veronika Žižkova; Mario Štefanić; Ljubica Glavaš-Obrovac; Saška Marczi; Marina Samardžija; Katerina Sikorova; Martin Petrek
Journal:  Sci Rep       Date:  2020-03-26       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.